Amisulprid-Mepha 200
Amisulprid-Mepha 200 is a medicine authorised by Swissmedic under authorisation number 59514. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 July 2010 and the authorisation is valid without a time limit. ATC code N05AL05 places the medicine in the group Psycholeptics.
| Authorisation number | 59514 |
|---|---|
| Name | Amisulprid-Mepha 200 |
| Full name | Amisulprid-Mepha 200, Tabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N05AL05 |
| First authorisation | 05 July 2010 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Amisulprid-Mepha 200, Tabletten | B | 05 July 2010 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | N05AL05 | 01.05.0. | B |
| 2 | 90 | Tablette(n) | N05AL05 | 01.05.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Amisulprid-Mepha 200 authorised in Switzerland?
Yes. Amisulprid-Mepha 200 is authorised by Swissmedic under authorisation number 59514, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Amisulprid-Mepha 200 have?
Amisulprid-Mepha 200 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Amisulprid-Mepha 200?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.